Evidence map›Paper›PMID 34831268›Full record

ReviewCells2021

Viral Membrane Fusion Proteins and RNA Sorting Mechanisms for the Molecular Delivery by Exosomes.

Ilya Zubarev, Dmitry Vladimirtsev, Maria Vorontsova, Igor Blatov, Konstantin Shevchenko, Svetlana Zvereva, Evgenii A Lunev, Evgeny Faizuloev, Nikolay Barlev

Abstract readReview
In one paragraph

Review in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Optimization of CRISPR-Cas system for clinical cancer therapy.Bioengineering & translational medicine · 2023
    Review
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ilya ZubarevFaculty of Medicine, Lomonosov Moscow State University, 119991 Moscow, Russia.ORCID 0000-0002-7827-498X
Dmitry VladimirtsevLaboratory of Intracellular Signaling, Moscow Institute of Physics and Technology, 141701 Moscow, Russia.
Maria VorontsovaFaculty of Medicine, Lomonosov Moscow State University, 119991 Moscow, Russia.
Igor BlatovLaboratory of Intracellular Signaling, Moscow Institute of Physics and Technology, 141701 Moscow, Russia.
Konstantin ShevchenkoInstitute of Cytology RAS, 194064 St. Petersburg, Russia.
Svetlana ZverevaLaboratory of Intracellular Signaling, Moscow Institute of Physics and Technology, 141701 Moscow, Russia.
Evgenii A LunevInstitute of Gene Biology, Russian Academy of Sciences, 119334, Moscow, Russia.ORCID 0000-0002-1361-6117
Evgeny FaizuloevI. Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia.ORCID 0000-0001-7385-5083
Nikolay BarlevLaboratory of Intracellular Signaling, Moscow Institute of Physics and Technology, 141701 Moscow, Russia.

Funding

Ministry of Science and Higher Education of the Russian Federation 75-15-2020-913
6 · The paper itself

Abstract

The advancement of precision medicine critically depends on the robustness and specificity of the carriers used for the targeted delivery of effector molecules in the human body. Numerous nanocarriers have been explored in vivo, to ensure the precise delivery of molecular cargos via tissue-specific targeting, including the endocrine part of the pancreas, thyroid, and adrenal glands. However, even after reaching the target organ, the cargo-carrying vehicle needs to enter the cell and then escape lysosomal destruction. Most artificial nanocarriers suffer from intrinsic limitations that prevent them from completing the specific delivery of the cargo. In this respect, extracellular vesicles (EVs) seem to be the natural tool for payload delivery due to their versatility and low toxicity. However, EV-mediated delivery is not selective and is usually short-ranged. By inserting the viral membrane fusion proteins into exosomes, it is possible to increase the efficiency of membrane recognition and also ease the process of membrane fusion. This review describes the molecular details of the viral-assisted interaction between the target cell and EVs. We also discuss the question of the usability of viral fusion proteins in developing extracellular vesicle-based nanocarriers with a higher efficacy of payload delivery. Finally, this review specifically highlights the role of Gag and RNA binding proteins in RNA sorting into EVs.

Indexed as

RNA TransportAnimalsExosomesHost-Pathogen InteractionsHumansMembrane FusionViral Fusion ProteinsViral Matrix ProteinsViral Fusion ProteinsViral Matrix Proteinsextracellular vesiclesfusion proteinRNA sortingtarget delivery

Identifiers

PMID34831268
PMCPMC8622164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.